Marker Therapeutics, Inc. (MRKR): Price and Financial Metrics
MRKR Price/Volume Stats
| Current price | $3.66 | 52-week high | $6.16 |
| Prev. close | $4.05 | 52-week low | $2.44 |
| Day low | $3.60 | Volume | 37,700 |
| Day high | $4.11 | Avg. volume | 25,432 |
| 50-day MA | $3.21 | Dividend yield | N/A |
| 200-day MA | $4.05 | Market Cap | 32.66M |
MRKR Stock Price Chart Interactive Chart >
Marker Therapeutics, Inc. (MRKR) Company Bio
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications.
MRKR Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...